We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
-11.62%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.03B
AUM Growth
-$132M
Cap. Flow
+$20.6M
Cap. Flow %
2.01%
Top 10 Hldgs %
29.82%
Holding
462
New
17
Increased
58
Reduced
119
Closed
62

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$11.1M
2
GEN icon
Gen Digital
GEN
+$9.34M
3
GRMN
Garmin
GRMN
+$9.3M
4
UNFI icon
United Natural Foods
UNFI
+$9.22M
5
AMGN icon
Amgen
AMGN
+$5.68M

Sector Composition

Rank Sector Weight
1 Healthcare 17.34%
2 Technology 16.69%
3 Industrials 11.06%
4 Financials 10.91%
5 Consumer Discretionary 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICI icon
451
VICI Properties
VICI
$29.4B
-105
Closed -$3K
VLY icon
452
Valley National Bancorp
VLY
$8.05B
-340
Closed -$4K
VOE icon
453
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
-194
Closed -$29K
VOT icon
454
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
-65
Closed -$14K
WKHS icon
455
Workhorse Group
WKHS
$36.3M
0
WMB icon
456
Williams Companies
WMB
$86.1B
-951
Closed -$32K
XLF icon
457
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
-1,635
Closed -$63K
XLI icon
458
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
-500
Closed -$51K
XRAY icon
459
Dentsply Sirona
XRAY
$2.43B
-363
Closed -$18K
MDC
460
DELISTED
M.D.C. Holdings, Inc.
MDC
-50
Closed -$2K
SPLK
461
DELISTED
Splunk Inc
SPLK
-50
Closed -$7K
CERN
462
DELISTED
Cerner Corp
CERN
-6,674
Closed -$624K

Similar funds

Atwood & Palmer's Q2 2022 Portfolio in Review

As of Q2 2022, Atwood & Palmer held 462 positions worth $1.03B, down 11% from $1.16B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Atwood & Palmer's Q2 2022 filing shows 17 new, 58 increased, 119 reduced and 62 closed positions. Its largest new stake was United Therapeutics: 54,788 shares worth $12.9M. The largest sale was iShares Preferred and Income Securities ETF, an estimated $8.97M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Atwood & Palmer's largest Q2 2022 buy was United Therapeutics: 54,788 shares worth $12.9M.
  • Atwood & Palmer added most to Garmin in Q2 2022, an estimated $9.3M increase.
  • Atwood & Palmer's biggest Q2 2022 reduction was iShares Preferred and Income Securities ETF, cutting an estimated $8.97M.
  • Atwood & Palmer fully exited Cerner Corp in Q2 2022, selling an estimated $624K.
  • Atwood & Palmer's ten largest holdings make up 30% of its $1.03B portfolio in Q2 2022.
  • Atwood & Palmer opened 17 new positions and closed 62 in Q2 2022.
  • Atwood & Palmer's portfolio value fell 11% quarter-over-quarter to $1.03B.

Based on Atwood & Palmer's 13F filing for Q2 2022, filed 21 Jul 2022.